Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Dec;16(1):2449722.
doi: 10.1080/21505594.2025.2449722. Epub 2025 Jan 10.

Klebsiella pneumoniae derived outer membrane vesicles mediated bacterial virulence, antibiotic resistance, host immune responses and clinical applications

Affiliations
Review

Klebsiella pneumoniae derived outer membrane vesicles mediated bacterial virulence, antibiotic resistance, host immune responses and clinical applications

Lifeng Li et al. Virulence. 2025 Dec.

Abstract

Klebsiella pneumoniae is a gram-negative pathogen that can cause multiple diseases including sepsis, urinary tract infections, and pneumonia. The escalating detections of hypervirulent and antibiotic-resistant isolates are giving rise to growing public concerns. Outer membrane vesicles (OMVs) are spherical vesicles containing bioactive substances including lipopolysaccharides, peptidoglycans, periplasmic and cytoplasmic proteins, and nucleic acids. Emerging studies have reported various roles of OMVs in bacterial virulence, antibiotic resistance, stress adaptation, and host interactions, whereas knowledge on their roles in K. pneumoniae is currently unclear. In this review, we summarized recent progress on the biogenesis, components, and biological function of K. pneumoniae OMVs, the impact and action mechanism in virulence, antibiotic resistance, and host immune response. We also deliberated on the potential of K. pneumoniae OMVs in vaccine development, as diagnostic biomarkers, and as drug nanocarriers. In conclusion, K. pneumoniae OMVs hold great promise in the prevention and control of infectious diseases, which merits further investigation.

Keywords: Klebsiella pneumoniae; Outer membrane vesicles; clinical application; host immune responses; virulence.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Characterization, biological functions, action mechanisms, and potential application of K. pneumoniae OMVs. The identification of OMVs mainly includes the morphology, size, and composition of OMVs. OMVs play roles in bacterial antibiotic resistance, virulence, pathogenesis, horizontal gene transfer, and host immune responses via different cells. OMVs are present in various body fluids after infection; hence, it may serve as a potential biomarker for the clinical identification of bacterial infection. OMVs are also utilized in the vaccine development and drug delivery to combat related infectious diseases. Drawn by BioRender and modified by Microsoft PowerPoint.
Figure 2.
Figure 2.
Schematic figure of OMV formation by outer membrane blebbing in Klebsiella pneumoniae. Abbreviations: OM, out membrane; PG, peptidoglycan; IM, inner membrance. Drawn by BioRender and modified by Microsoft PowerPoint.
Figure 3.
Figure 3.
Immune responses of host cells against Klebsiella pneumoniae outer membrane vesicles. (a) OMV–epithelial cell interaction. (b) OMV–macrophage interaction. OMVs consist of lipopolysaccharide (LPS), outer membrane proteins, porin, bacterial DNA, etc., which are recognized by host pathogen recognition receptors, such as the membrane-bound toll-like receptor 4 (TLR4), and induce a downstream immune response and the production of proinflammatory cytokines. The immune responses mainly include the activation of pattern recognition receptors, regulation of cytokine release pathways, inflammasome activation, and miRNA-mediated pathways. Abbreviations: OMV, out membrane vesicle; toll-like receptor 4, TLR4; OMVs isolated from multidrug-resistant K. pneumoniae treated with imipenem, KOMVs-imp. Drawn by Figdraw.

References

    1. Li L, Ma J, Cheng P, et al. Roles of two-component regulatory systems in Klebsiella pneumoniae: regulation of virulence, antibiotic resistance, and stress responses. Microbiol Res. 2023;272:127374. doi: 10.1016/j.micres.2023.127374 - DOI - PubMed
    1. Yang X, Dong N, Chan EW, et al. Carbapenem resistance-encoding and virulence-encoding conjugative plasmids in Klebsiella pneumoniae. Trends Microbiol. 2021;29(1):65–15. doi: 10.1016/j.tim.2020.04.012 - DOI - PubMed
    1. Chen T, Wang Y, Chi X, et al. Genetic, virulence, and antimicrobial resistance characteristics associated with distinct morphotypes in ST11 carbapenem-resistant Klebsiella pneumoniae. Virulence. 2024;15(1):2349768. doi: 10.1080/21505594.2024.2349768 - DOI - PMC - PubMed
    1. Gu D, Dong N, Zheng Z, et al. A fatal outbreak of ST11 carbapenem-resistant hypervirulent Klebsiella pneumoniae in a Chinese hospital: a molecular epidemiological study. Lancet Infect Dis. 2018;18(1):37–46. doi: 10.1016/S1473-3099(17)30489-9 - DOI - PubMed
    1. Wu Y, Wu C, Bao D, et al. Global evolution and geographic diversity of hypervirulent carbapenem-resistant Klebsiella pneumoniae. The Lancet Infect Dis. 2022;22(6):761–762. doi: 10.1016/S1473-3099(22)00275-4 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources